Lisata Therapeutics Inc. (LSTA)
NASDAQ · Healthcare
Lisata Therapeutics Inc. EPS 2010–2025
Lisata Therapeutics Inc. annual/quarterly eps history and growth rate from 2016 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Lisata Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.50, a 9.09% decrease year-over-year.
- Lisata Therapeutics Inc. annual eps for 2025 was $1.91, a 20.42% decrease from 2024.
- Lisata Therapeutics Inc. annual eps for 2024 was $2.40, a 6.98% decrease from 2023.
- Lisata Therapeutics Inc. annual eps for 2023 was $2.58, a 75.36% decrease from 2022.
- Lisata Therapeutics Inc. annual eps for 2022 was $10.47.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Lisata Therapeutics Inc. EPS — FAQ
Lisata Therapeutics Inc. (LSTA) eps over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Lisata Therapeutics Inc.'s eps?
Lisata Therapeutics Inc. (LSTA) reported eps of $-1.91 for fiscal 2025.
Where can I see LSTA's eps history?
The chart and table above show Lisata Therapeutics Inc.'s eps by year and by quarter, including the growth rate.